Barotrauma Market Size, Share, Type, Treatment, Growth, Regional Overview, Segments, Demand and Forecast to 2023

MRFR Provides Appropriate Analysis of Global Barotrauma Market by Geographical Analysis, Scope, Applications, Products, Prominent Audience, End Users, and Market Players for Global, and Country Level Market Segments, etc

Pune, India - March 20, 2019 /MarketersMedia/ —

Market Highlights:

Owing to the increasing cases of ear barotrauma, technological advancements, increasing healthcare expenditure, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the barotrauma market has evolved significantly.

However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in the low and middle-income countries are likely to hamper the growth of the barotrauma market over the forecast period.

It is estimated that the barotrauma market is expected to have a CAGR of 6.5% during the forecast period of 2017–2023.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5899

Top Players:

Some of the key players in the global barotrauma market are 3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.

Segmentation:

The global barotrauma market is segmented by type, diagnosis, treatment, and end-user.

On the basis of type, the barotrauma market is classified as ear barotrauma, sinus barotrauma, and pulmonary (lung) barotrauma.

On the basis of diagnosis, the barotrauma market is classified as otoscopy, X-ray, Computed Tomography (CT) scan, pulmonary function test, lung perfusion scan, Magnetic Resonance Imaging (MRI), pulse oximetry, and others.

On the basis of treatment, the barotrauma market is classified as pressure relief, medications, surgery, oxygen treatment, recompression therapy, and others. The medications segment is further classified as decongestant nasal sprays, oral decongestants, oral antihistamines, painkillers, antibiotics, and others. The surgery segment is further classified as Functional Endoscopic Sinus Surgery (FESS), tympanostomy, Single Laparoscopic Incision Transabdominal (SLIT), and others.

On the basis of end-user, the barotrauma market is segmented into hospitals and clinics, trauma centers, pharmaceutical companies, medical device companies, academic and research institutes, and others.

Regional outlook:

The Americas dominates the barotrauma market owing to the increasing prevalence of ear barotrauma and high healthcare expenditure.

Europe holds the second position in the barotrauma market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European barotrauma market. The increasing healthcare expenditure is also boosting the European barotrauma market.

According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.

Asia Pacific is the fastest growing barotrauma market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.

The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.

Browse Complete 100 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/barotrauma-market-5899

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/barotrauma-market-5899

Source URL: https://marketersmedia.com/barotrauma-market-size-share-type-treatment-growth-regional-overview-segments-demand-and-forecast-to-2023/494035

Source: MarketersMedia

Release ID: 494035

More News From Banking Reporter

German government halves 2019 growth forecast to 0.5%

Apr 18, 2019

BERLIN — The German government has slashed its 2019 economic growth forecast for the country for the second time this year and is now predicting growth of only 0.5%. Wednesday's forecast halves the 1% estimate the government presented in late January, when it cut its forecast from 1.8%. It follows a string of downgrades by economists and other groups. Economy Minister Peter Altmaier predicted growth of 1.5% in 2020. Prospects for Germany, Europe's biggest economy, have been weighed down by weaker growth elsewhere and by the after-effects of its own weak performance at the end of last year, when it...

German economy gets positive signal amid slowdown

Apr 18, 2019

FRANKFURT, Germany — An index of investor sentiment about Germany bounced higher in April, adding to the contradictory signals about the strength of Europe's largest economy. The ZEW index published Tuesday rose for the sixth straight month, to plus 3.1 from minus 3.6 in March. The German economy registered no growth at the end of 2018 and manufacturing data has been weak amid slowing global trade. The weak points have been offset by low unemployment and rising wages, raising hopes for a modest rebound this year. Analyst Carsten Brzeski of bank ING-DiBa said the index was boosted by better economic...

World stocks mostly rise on US-China trade talks, earnings

Apr 18, 2019

SINGAPORE — World stocks mostly edged up on Monday after the U.S. and China said they were closing in on a trade deal, without giving a timeline, and amid optimism over corporate earnings. Britain's FTSE 100 was flat at 7,433 while the CAC 40 in France gained 0.1% to 5,509. Germany's DAX was also up 0.1%, at 12,017. On Wall Street, the future contract for the broad S&P 500 index was flat, while that for the Dow Jones Industrial Average was 0.2% higher. U.S. Treasury Secretary Steven Mnuchin said Saturday that the U.S. and China were moving closer to an...

South Korean president calls for 4th summit with Kim Jong Un

Apr 18, 2019

SEOUL, South Korea — South Korean President Moon Jae-in said Monday he's ready for a fourth summit with North Korean leader Kim Jong Un to help salvage faltering nuclear negotiations between the North and the United States. Moon's comments came after Kim issued his harshest criticism yet of South Korea's diplomatic role last week, accusing Seoul of acting like an "overstepping mediator" and demanding that it diverge from Washington to support the North's position more strongly. Moon met Kim three times last year and also brokered nuclear talks between North Korea and the U.S. following tensions created by the North's...

WTO upholds South Korean ban on Fukushima seafood

Apr 18, 2019

SEOUL, South Korea — The World Trade Organization has upheld South Korea's import ban on Japanese seafood from areas affected by the 2011 nuclear disaster in Fukushima, overturning a ruling by a lower panel last year that said Seoul was unfairly discriminating against Japanese products. The decision is a setback for Japan, which has promoted Fukushima's recovery from the nuclear disaster and the safety of its agricultural and fisheries products ahead of next year's Summer Olympics in Tokyo. South Korea on Friday welcomed the decision and said it will continue to block all fishery products from Fukushima and seven neighboring...

About Us

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.

Contact us: sales[at]bankingreporter.com

Subscribe Now!